NCT04272372View on ClinicalTrials.gov

Lymphedema Treatment Registry

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2025

Conditions
Breast Cancer Lymphedema
Interventions
DRUG

Ketoprofen

PO and local therapy

All Listed Sponsors
collaborator

Turkish Lymphedema Society

UNKNOWN

collaborator

The Breast Health Society, Turkey

OTHER

lead

Ege University

OTHER

NCT04272372 - Lymphedema Treatment Registry | Biotech Hunter | Biotech Hunter